Literature DB >> 8362969

Interstitial collagenase gene expression in colonic neoplasia.

S T Gray1, K Yun, T Motoori, Y M Kuys.   

Abstract

Tumor invasion and metastasis are complex phenomena believed to be facilitated by the disruption of collagen and elastin fibers in the extracellular matrix. Interstitial collagenase gene expression was studied in colonic adenocarcinoma and adenoma using in situ hybridization. The data indicated that three cell types within the tumor stroma expressed collagenase transcripts; they were eosinophils, fibroblasts, and vascular endothelium. In all 12 adenocarcinomas, a high to moderate level of expression was seen in 1 to 5% of eosinophils and in occasional fibroblasts, whereas these cell types in non-neoplastic mucosa adjacent to tumor showed no detectable expression. Two adenocarcinomas showed expression in hyperplastic endothelium in vascularized granulation tissue. Two out of three adenomas showed expression in eosinophils and fibroblasts at a reduced level. Tissue inhibitor of metalloproteinase-1 gene expression was, however, negligible in all tissue examined. These results suggest that interstitial collagenase gene activation in the tumor stroma, especially eosinophils, may have an important role in tumor invasion and metastasis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8362969      PMCID: PMC1887216     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  48 in total

Review 1.  Metalloproteinases and their inhibitors in matrix remodeling.

Authors:  L M Matrisian
Journal:  Trends Genet       Date:  1990-04       Impact factor: 11.639

2.  Tumor-associated eosinophilotactic factor.

Authors:  S I Wasserman; E J Goetzl; L Ellman; K F Austen
Journal:  N Engl J Med       Date:  1974-02-21       Impact factor: 91.245

3.  Antigens of the basement membrane and the peritumoral stroma in human colonic adenocarcinomas: an immunofluorescence study.

Authors:  P Burtin; G Chavanel; J M Foidart; E Martin
Journal:  Int J Cancer       Date:  1982-07-15       Impact factor: 7.396

4.  Enhanced collagenase production by fibroblasts derived from human basal cell carcinomas.

Authors:  E A Bauer; J Uitto; R C Walters; A Z Eisen
Journal:  Cancer Res       Date:  1979-11       Impact factor: 12.701

5.  Collagenase production by synovial fibroblasts treated with phorbol myristate acetate.

Authors:  C E Brinckerhoff; R M McMillan; J V Fahey; E D Harris
Journal:  Arthritis Rheum       Date:  1979-10

6.  Eosinophil infiltration of human colonic carcinomas as a prognostic indicator.

Authors:  T P Pretlow; E F Keith; A K Cryar; A A Bartolucci; A M Pitts; T G Pretlow; P M Kimball; E A Boohaker
Journal:  Cancer Res       Date:  1983-06       Impact factor: 12.701

7.  Pathology of colorectal adenomas: a colonoscopic survey.

Authors:  F Konishi; B C Morson
Journal:  J Clin Pathol       Date:  1982-08       Impact factor: 3.411

8.  A light microscopical study of healing incised dermal wounds in rats, with special reference to eosinophil leucocytes and to the collagenous fibres of the periwound areas.

Authors:  E G Bassett; J R Baker; P de Souza
Journal:  Br J Exp Pathol       Date:  1977-12

9.  Rat mammary carcinoma cells secrete active collagenase and activate latent enzyme in the stroma via plasminogen activator.

Authors:  R L O'Grady; L I Upfold; R W Stephens
Journal:  Int J Cancer       Date:  1981-10-15       Impact factor: 7.396

Review 10.  Tumour-associated eosinophilia: a review.

Authors:  D Lowe; J Jorizzo; M S Hutt
Journal:  J Clin Pathol       Date:  1981-12       Impact factor: 3.411

View more
  9 in total

Review 1.  Matrix metalloproteinases. Novel targets for directed cancer therapy.

Authors:  A E Yu; R E Hewitt; E W Connor; W G Stetler-Stevenson
Journal:  Drugs Aging       Date:  1997-09       Impact factor: 3.923

2.  Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas.

Authors:  A Okada; J P Bellocq; N Rouyer; M P Chenard; M C Rio; P Chambon; P Basset
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

3.  Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas.

Authors:  I Bolon; V Gouyer; M Devouassoux; B Vandenbunder; N Wernert; D Moro; C Brambilla; E Brambilla
Journal:  Am J Pathol       Date:  1995-11       Impact factor: 4.307

4.  Erythromycin and clarithromycin modulation of growth factor-induced expression of heparanase mRNA on human lung cancer cells in vitro.

Authors:  M Sasaki; T Ito; M Kashima; S Fukui; N Izumiyama; A Watanabe; M Sano; Y Fujiwara; M Miura
Journal:  Mediators Inflamm       Date:  2001-10       Impact factor: 4.711

5.  The clinical significance of MMP-1 expression in oesophageal carcinoma.

Authors:  K Yamashita; M Mori; A Kataoka; H Inoue; K Sugimachi
Journal:  Br J Cancer       Date:  2001-01       Impact factor: 7.640

6.  Marimastat in recurrent colorectal cancer: exploratory evaluation of biological activity by measurement of carcinoembryonic antigen.

Authors:  J N Primrose; H Bleiberg; F Daniel; S Van Belle; J L Mansi; M Seymour; P W Johnson; J P Neoptolemos; M Baillet; K Barker; A Berrington; P D Brown; A W Millar; K P Lynch
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

7.  Expression of interstitial collagenase (matrix metalloproteinase-1) in gastric cancers.

Authors:  Y Sakurai; Y Otani; K Kameyama; Y Hosoda; I Okazaki; T Kubota; K Kumai; M Kitajima
Journal:  Jpn J Cancer Res       Date:  1997-04

8.  Expression of collagenase (MMP2), stromelysin (MMP3) and tissue inhibitor of the metalloproteinases (TIMP1) in pancreatic and ampullary disease.

Authors:  S R Bramhall; G W Stamp; J Dunn; N R Lemoine; J P Neoptolemos
Journal:  Br J Cancer       Date:  1996-04       Impact factor: 7.640

9.  Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans.

Authors:  A E Kossakowska; S A Huchcroft; S J Urbanski; D R Edwards
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.